BOSTON–(BUSINESS WIRE)–Sonde Health Inc., a company developing a voice-based technology platform for monitoring and diagnosing mental and physical medical conditions, today announced the completion of a $16 million Series A financing round, including the issuance of $6 million in shares upon conversion of debt into equity. The round was led by M Ventures (the corporate …
PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to note that Sonde Health, an affiliate of PureTech Health, today announced the appointment of Thai Lee to its Board of Directors. Ms Lee is recognised as a prominent business leader in the information technology industry and brings …
This week has spurred some major patent announcements from digital health companies Akili Interactive and Sonde Health, which are both affiliated with PureTech Health, a cross disciplinary biopharma company. The two companies announced they have been granted the rights to multiple international digital health patents. Akili revealed they are developing a technology aimed at using …
Digital therapeutics can help people make positive and sustainable behavior change that can be as effective as taking a medication. It’s time to break free of the traditional paradigms of disease management and embrace the future by leveraging technology to fully realize the benefits of therapeutics.
How you talk could reveal heart disease or concussions, say researchers and companies developing the novel technology.
There’s long been talk in medicine about the need to listen more to the patient voice — and now that mantra is being taken literally.
Boston-based Sonde Health, a recent spin-out of PureTech Health, has licensed a health-focused voice scanning technology from MIT’s Lincoln Laboratories.
The development of vocal biomarkers to detect things like depression and stress has been an area of interest for some time.
PureTech Health starts companies in cutting-edge areas of biomedical science and often owns them outright. Its latest aims to create software that listens for warning signs of depression in people’s speech patterns.
Sonde Health is developing voice-based technologies capable of diagnosing medical conditions by analyzing vocal biomarkers—acoustic characteristics in the speakers voice.
Life sciences incubator PureTech Health (LON:PRTC), unfazed by the worldwide impact of the U.K.’s vote to leave the European Union, announced its latest venture today: Sonde Health, which aims to use a voice-based technology to diagnose mental and physical ailments.
They’re analyzing audio clips from users’ devices to find mental & physical ailments.
Company licenses MIT technology and collaborates with experts to objectively diagnose and monitor medical concerns through vocal cues.